Welcome to the ViiV Exchange

for Healthcare Professionals

The ViiV Exchange is an online portal for access to the latest information on ViiV Healthcare's medicines.

LOGIN REGISTER

SINGLE STUDY DATA UP TO 144 WEEKS

Efficacy and safety of dolutegravir (DTG) in treatment-naïve subjects

View SINGLE Slide Set

Guidelines

DHHS, IAS, EACS

International Guidelines support the use of Dolutegravir due to its Efficacy

See Guidelines

Latest Videos

Why is DTG their Core?
Robust Efficacy

Play this video
Duration
1:46
Date
June 2017

Introduction

Play this video
Duration
4:29
Date
April 2017

Pharmacology

Play this video
Duration
17:10
Date
April 2017

Are you interested in other news around HIV?

E.g.: General questions/answers about HIV
E.g.: Swiss HIV calendar

Please visit: ViiV Healthcare Switzerland

LOGIN TO VIEW ARTICLES

Please find presentations from ViiV Healthcare on our medicines, or other latest topics around HIV.

Read more
Conference Conference Conference

Our Medicines

Please login to view Our Medicines

Do you have questions about any of our products?

In case you want to get further information about our products, arrange a meeting, or provide feedback to this page, please use our contact form.

Contact form

Resources

What's new